HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.

Abstract
Acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) is associated with significant morbidity and mortality. In the present study, we retrospectively evaluated whether soluble interleukin-2 receptor (sIL-2R) index, defined as the ratio of serum sIL-2R levels at neutrophil engraftment to those at the pre-conditioning regimen, was predictive of acute GVHD among 51 patients who underwent allogeneic HSCT as their first transplantation and achieved engraftment. The median sIL-2R index was 3.6, and the sIL-2R values were positively associated with acute GVHD severity (grade 0-I: 3.8 ± 2.0 vs. grade II-IV: 7.1 ± 5.7; P = 0.05). Grade II-IV acute GVHD had a cumulative incidence of 31.4 %, and was significantly more frequent among patients with an sIL-2R index of ≥4.5 (≥4.5: 50.0 % vs. <4.5: 21.2 %; P = 0.03). Multivariate analysis revealed that an sIL-2R index of ≥4.5 [hazard ratio (HR) 3.5, P < 0.01] and donor age of >35 years (HR 3.8, P = 0.02) were significant risk factors for grade II-IV acute GVHD. Therefore, increased sIL-2R levels from baseline to engraftment might predict the risk of moderate-to-severe acute GVHD after allogeneic HSCT from an unrelated donor.
AuthorsYukinori Nakamura, Yoshinori Tanaka, Mayumi Tanaka, Akiko Sugiyama, Kaoru Yamamoto, Yoshihiro Tokunaga, Toshiaki Yujiri, Yukio Tanizawa
JournalInternational journal of hematology (Int J Hematol) Vol. 103 Issue 4 Pg. 436-43 (Apr 2016) ISSN: 1865-3774 [Electronic] Japan
PMID26791380 (Publication Type: Journal Article)
Chemical References
  • Receptors, Interleukin-2
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Graft vs Host Disease (blood, diagnosis, etiology)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Middle Aged
  • Receptors, Interleukin-2 (blood)
  • Retrospective Studies
  • Survival Analysis
  • Transplantation, Homologous
  • Unrelated Donors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: